Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers

Authors

Adam D. Pfefferle, University of North Carolina at Chapel Hill
Yash N. Agrawal, University of North Carolina at Chapel Hill
Daniel C. Koboldt, Washington University School of Medicine in St. Louis
Krishna L. Kanchi, Washington University School of Medicine in St. Louis
Jason I. Herschkowitz, University of Albany
Elaine R. Mardis, Washington University School of Medicine in St. Louis
Jeffrey M. Rosen, Baylor College of Medicine
Charles M. Perou, University of North Carolina at Chapel Hill

Journal

Disease Models & Mechanisms

Publication Date

2016

Volume

2016

Issue

9

Inclusive Pages

749-757

Document Type

Open Access Publication

DOI

10.1242/dmm.025239

Rights and Permissions

Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers Adam D. Pfefferle, Yash N. Agrawal, Daniel C. Koboldt, Krishna L. Kanchi, Jason I. Herschkowitz, Elaine R. Mardis, Jeffrey M. Rosen, Charles M. Perou Disease Models and Mechanisms 2016 9: 749-757; doi: 10.1242/dmm.025239

Recommended Citation

Pfefferle, Adam D.; Agrawal, Yash N.; Koboldt, Daniel C.; Kanchi, Krishna L.; Herschkowitz, Jason I.; Mardis, Elaine R.; Rosen, Jeffrey M.; and Perou, Charles M., "Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers." Disease Models & Mechanisms. 2016, 9. 749-757. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5079